Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

NCOA3 (Nuclear Receptor Coactivator 3)

Identity

Other namesAIB1 (amplified in breast cancer-1)
ACTR
RAC3 (RAR-associated coactivator 3)
SRC3 (steroid receptor coactivator protein 3)
TRAM-1 (thyroid hormone receptor activator molecule 1)
pCIP (p300/CBP-integrator associated protein; mouse)
Hugo NCOA3
Location 20q13.1
 
  AIB1 (20q12)

DNA/RNA

 
  Genomic structure of NCOA3 with NCBI Build 35.1 genomic positions indicated. Black boxes indicate exons. The translational start (*) and stop codons (^) are also shown. UTR, untranslated region.
Description The human AIB1 gene spans approximately155 kb and has 23 exons. RNA Expression: Highly expressed in placenta, heart, pancreas, muscle, brain, liver, uterus, pituitary, mammary gland, and testis. Lower levels of expression are found in lung and kidney.
Transcription Transcription is from centromere to telomere. There are two reported transcripts: Isoform a (7935 bp) and isoform b (7923 bp). Isoform b uses an alternate in-frame splice site and lacks exon 3.
Pseudogene Chromosome 8 (AF010227)

Protein

 
  Structural features of AIB1. AIB1 contains a basic helix-loop-helix preceding a PAS (Per/Arnt/Sim) region, serine-and threonine-rich regions, and a charged cluster. There is also a glutamine-rich region that contains a polyglutamine tract. The central portion of the protein contains three LXXLL motifs (L=leucine, X=any amino acid) that are critical for interaction with ligand-bound nuclear receptors. An activation domain located C-terminal to the nuclear receptor interaction domain contains three LXXLL motifs that are important for interaction with general transcription cointegrators, CREB binding protein (CBP)/p300. A second transcriptional activation domain is responsible for interaction with histone methyltransferases, coactivator-associated arginine methyltranserase 1 (CARM1) and PRMT1.
Description A member of the p160/steroid receptor coactivator family. 1424 amino acids. 155 kDa (130 kDa encoded by isoform b).
Expression Protein expression found in testis, lung, liver, brain, mammary gland, and heart.
Localisation Mainly cytoplasmic and weakly nuclear. The protein translocates to the nucleus upon TNF activation and phosphorylation.
Function A transcriptional coactivator that interacts with nuclear hormone receptors to enhance their transcriptional activation. AIB1 interacts with other transcription factors including TP52, NfkB, and ER81. It has intrinsic histone acytyltransferase activity and recruits CREB Binding Protein (CBP)/p300 cointegrators to a multisubunit coactivator complete.

Mutations

Somatic The gene copy number and expression levels are altered in several cancer types. Overexpression has been found in breast, ovarian, endometrial, gastric, and pancreatic cancers. Amplification of AIB1 in hepatocellular carcinoma is associated with poor prognosis. Increased numbers of polyglutamine repeats correlate with higher breast cancer risk in BRCA1 and BRCA2 mutation carriers. However, the polymorphic repeat genotype does not influence postmenopausal breast cancer risk among Caucasian women in the general population.

To be noted

Overexpression of AIB1 in tamoxifen-treated patients is associated with tamoxifen resistance and worse survival. Tamoxifen behaves as estrogen in breast cancer cells that express high levels of AIB1 and HER2, resulting in de novo resistance.

An N-terminally deleted isoform (AIB1-Delta3) which lacks exon 3 was identified and found to be overexpressed in breast cancer cell lines and in tumors from breast cancer patients. Of interest, this splice variant has more potent transcriptional coactivation properties on estrogen and progesterone receptors than the full-length AIB1 protein.

External links

Nomenclature
HugoNCOA3
GDBNCOA3
Entrez_GeneNCOA3  8202  nuclear receptor coactivator 3
Cards
AtlasNCOA3ID505ch20q13
GeneCardsNCOA3
EnsemblNCOA3 [Search_View]   ENSG00000124151 [Gene_View]
GenatlasNCOA3
GeneLynxNCOA3
eGenomeNCOA3
euGene8202
Genomic and cartography
GoldenPathNCOA3  -  20q13.1   chr20:45564064-45719019 +  20q12   [Description]    (hg18-Mar_2006)
EnsemblNCOA3 - 20q12 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneNCOA3
Gene and transcription
GenbankAB209863 [ ENTREZ ]
GenbankAF010227 [ ENTREZ ]
GenbankAF012108 [ ENTREZ ]
GenbankAF016031 [ ENTREZ ]
GenbankAF036892 [ ENTREZ ]
RefSeqNM_006534 [ SRS ]    NM_006534 [ ENTREZ ]
RefSeqNM_181659 [ SRS ]    NM_181659 [ ENTREZ ]
RefSeqAC_000063 [ SRS ]    AC_000063 [ ENTREZ ]
RefSeqNC_000020 [ SRS ]    NC_000020 [ ENTREZ ]
RefSeqNT_011362 [ SRS ]    NT_011362 [ ENTREZ ]
RefSeqNW_927339 [ SRS ]    NW_927339 [ ENTREZ ]
AceViewNCOA3 AceView - NCBI
UnigeneHs.592142 [ SRS ]    Hs.592142 [ NCBI ]     HS592142 [ spliceNest ]
Fast-db12948 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtQ9Y6Q9 [ SRS]    Q9Y6Q9 [ EXPASY ]     Q9Y6Q9 [ INTERPRO ]
PrositePS50888 HLH [ SRS ]    PS50888 HLH [ Expasy ]
PrositePS50112 PAS [ SRS ]    PS50112 PAS [ Expasy ]
InterproIPR010011 DUF1518 [ SRS ]    IPR010011 DUF1518 [ EBI ]
InterproIPR001092 HLH_basic [ SRS ]    IPR001092 HLH_basic [ EBI ]
InterproIPR014920 Nuc_rcpt_coact_Ncoa-typ [ SRS ]    IPR014920 Nuc_rcpt_coact_Ncoa-typ [ EBI ]
InterproIPR000014 PAS [ SRS ]    IPR000014 PAS [ EBI ]
InterproIPR013767 PAS_fold [ SRS ]    IPR013767 PAS_fold [ EBI ]
InterproIPR014935 SRC-1 [ SRS ]    IPR014935 SRC-1 [ EBI ]
CluSTrQ9Y6Q9
PfamPF07469 DUF1518 [ SRS ]    PF07469 DUF1518 [ Sanger ]    pfam07469 [ NCBI-CDD ]
PfamPF00010 HLH [ SRS ]    PF00010 HLH [ Sanger ]    pfam00010 [ NCBI-CDD ]
PfamPF08815 Nuc_rec_co-act [ SRS ]    PF08815 Nuc_rec_co-act [ Sanger ]    pfam08815 [ NCBI-CDD ]
PfamPF00989 PAS [ SRS ]    PF00989 PAS [ Sanger ]    pfam00989 [ NCBI-CDD ]
PfamPF08832 SRC-1 [ SRS ]    PF08832 SRC-1 [ Sanger ]    pfam08832 [ NCBI-CDD ]
SmartSM00353 HLH [EMBL]
SmartSM00091 PAS [EMBL]
BlocksQ9Y6Q9
PDB1KBH [ SRS ]    1KBH [ PdbSum ],   1KBH [ IMB ]   1KBH [ RSDB ]
HPRD03570
Protein Interaction databases
DIPQ9Y6Q9
IntActQ9Y6Q9
Polymorphism : SNP, mutations, diseases
OMIM601937    [ map ]   
GENECLINICS601937
SNPNCOA3 [dbSNP-NCBI]  
SNPNM_006534 [SNP-NCI]  
SNPNM_181659 [SNP-NCI]  
SNPNCOA3 [GeneSNPs - Utah]  NCOA3] [HGBASE - SRS]
HAPMAPNCOA3 [HAPMAP]  
COSMICNCOA3 [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDNCOA3
General knowledge
Family BrowserNCOA3 [UCSC Family Browser]
SOURCENM_006534
SOURCENM_181659
SMDHs.592142
SAGEHs.592142
Enzyme2.3.1.48 [ Enzyme-SRS ]   2.3.1.48 [ Brenda-SRS ]   2.3.1.48 [ KEGG ]   2.3.1.48 [ WIT ]
GOtranscription coactivator activity [Amigo]  transcription coactivator activity
GOhistone acetyltransferase activity [Amigo]  histone acetyltransferase activity
GOsignal transducer activity [Amigo]  signal transducer activity
GOnucleus [Amigo]  nucleus
GOcytoplasm [Amigo]  cytoplasm
GOsignal transduction [Amigo]  signal transduction
GOacyltransferase activity [Amigo]  acyltransferase activity
GOtransferase activity [Amigo]  transferase activity
GOandrogen receptor signaling pathway [Amigo]  androgen receptor signaling pathway
GOtranscription regulator activity [Amigo]  transcription regulator activity
GOpositive regulation of transcription, DNA-dependent [Amigo]  positive regulation of transcription, DNA-dependent
GOthyroid hormone receptor binding [Amigo]  thyroid hormone receptor binding
GOprotein N-terminus binding [Amigo]  protein N-terminus binding
GOandrogen receptor binding [Amigo]  androgen receptor binding
BIOCARTATranscription Regulation by Methyltransferase of CARM1    [Genes]
BIOCARTANuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells    [Genes]
BIOCARTAControl of Gene Expression by Vitamin D Receptor    [Genes]
PubGeneNCOA3
TreeFamNCOA3
CTD8202 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeNCOA3 Related clones (RZPD - Berlin)
PubMed
PubMed93 Pubmed reference(s) in LocusLink

Bibliography

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS
Science (New York, N.Y.). 1997 ; 277 (5328) : 965-968.
PMID 9252329
 
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.
Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM
Cell. 1997 ; 90 (3) : 569-580.
PMID 9267036
 
RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.
Li H, Gomes PJ, Chen JD
Proceedings of the National Academy of Sciences of the United States of America. 1997 ; 94 (16) : 8479-8484.
PMID 9238002
 
TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.
Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW
The Journal of biological chemistry. 1997 ; 272 (44) : 27629-27634.
PMID 9346901
 
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.
Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG
Nature. 1997 ; 387 (6634) : 677-684.
PMID 9192892
 
In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
Bautista S, VallˆŽs H, Walker RL, Anzick S, Zeillinger R, Meltzer P, Theillet C
Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 ; 4 (12) : 2925-2929.
PMID 9865902
 
The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation.
Li H, Chen JD
The Journal of biological chemistry. 1998 ; 273 (10) : 5948-5954.
PMID 9488734
 
A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity.
Suen CS, Berrodin TJ, Mastroeni R, Cheskis BJ, Lyttle CR, Frail DE
The Journal of biological chemistry. 1998 ; 273 (42) : 27645-27653.
PMID 9765300
 
Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas.
Ghadimi BM, Schrˆck E, Walker RL, Wangsa D, Jauho A, Meltzer PS, Ried T
The American journal of pathology. 1999 ; 154 (2) : 525-536.
PMID 10027410
 
Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53.
Lee SK, Kim HJ, Kim JW, Lee JW
Molecular endocrinology (Baltimore, Md.). 1999 ; 13 (11) : 1924-1933.
PMID 10551785
 
Polymorphic repeat in AIB1 does not alter breast cancer risk.
Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Brown M, Hunter DJ
Breast cancer research : BCR. 2000 ; 2 (5) : 378-385.
PMID 11056690
 
Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers.
Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Kimura A, Nakamura Y, Inazawa J, Abe T, Yamagishi H
International journal of cancer. Journal international du cancer. 2000 ; 89 (3) : 217-223.
PMID 10861496
 
RAC-3 is a NF-kappa B coactivator.
Werbajh S, Nojek I, Lanz R, Costas MA
FEBS letters. 2000 ; 485 (2-3) : 195-199.
PMID 11094166
 
The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development.
Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW
Proceedings of the National Academy of Sciences of the United States of America. 2000 ; 97 (12) : 6379-6384.
PMID 10823921
 
Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas.
Glaeser M, Floetotto T, Hanstein B, Beckmann MW, Niederacher D
Hormone and metabolic research. Hormon- und Stoffwechselforschung. Hormones et metabolisme. 2001 ; 33 (3) : 121-126.
PMID 11355743
 
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.
Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M
Cancer research. 2001 ; 61 (14) : 5420-5424.
PMID 11454686
 
An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer.
Reiter R, Wellstein A, Riegel AT
The Journal of biological chemistry. 2001 ; 276 (43) : 39736-39741.
PMID 11502741
 
Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY
Cancer. 2002 ; 95 (11) : 2346-2352.
PMID 12436441
 
Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.
Watanabe T, Imoto I, Katahira T, Hirasawa A, Ishiwata I, Emi M, Takayama M, Sato A, Inazawa J
Japanese journal of cancer research : Gann. 2002 ; 93 (10) : 1114-1122.
PMID 12417041
 
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.
Wu RC, Qin J, Hashimoto Y, Wong J, Xu J, Tsai SY, Tsai MJ, O'Malley BW
Molecular and cellular biology. 2002 ; 22 (10) : 3549-3561.
PMID 11971985
 
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.
Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R
Journal of the National Cancer Institute. 2003 ; 95 (5) : 353-361.
PMID 12618500
 
Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.
Goel A, Janknecht R
The Journal of biological chemistry. 2004 ; 279 (15) : 14909-14916.
PMID 14747462
 
Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.
Henke RT, Haddad BR, Kim SE, Rone JD, Mani A, Jessup JM, Wellstein A, Maitra A, Riegel AT
Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 ; 10 (18 Pt 1) : 6134-6142.
PMID 15448000
 
Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.
Kadouri L, Kote-Jarai Z, Easton DF, Hubert A, Hamoudi R, Glaser B, Abeliovich D, Peretz T, Eeles RA
International journal of cancer. Journal international du cancer. 2004 ; 108 (3) : 399-403.
PMID 14648706
 
Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways.
Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ, O'Malley BW
Molecular cell. 2004 ; 15 (6) : 937-949.
PMID 15383283
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written04-2005Sarah L Anzick
Cancer Genetics Branch National Human Genome, Research Institute National Institutes of Health 50 South Drive, MSC 8000 Bldg. 50, Rm. 5148 Bethesda, MD 20892-8000, USA

Citation

This paper should be referenced as such :

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jul 2 08:25:22 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.